SG

Sukanta Ghosh

Active Director Director DIN 09557754
DIN 09557754 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sukanta Ghosh

Data last updated:

Sukanta Ghosh is a Director at Medifoster Private Limited (since 2022). The company operates in Chemicals.

DIN 09557754
Primary Designation Director
Industry Chemicals
First Appointment 31 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medifoster Private Limited U24290WB2022PTC252731
Director31 Mar 20222022Active

Board colleagues of Sukanta Ghosh

NameDINCompanyDesignation
Hemanta Naskar09314748Medifoster Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medifoster Private Limited
Premium access

Shareholding and investment profile for Sukanta Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukanta Ghosh

Sukanta Ghosh currently holds 1 directorship: Medifoster Private Limited (Director, since 31 Mar 2022).

Sukanta Ghosh was first appointed on 31 Mar 2022 as Director at Medifoster Private Limited.

The current boards of Sukanta Ghosh's companies include Hemanta Naskar (Medifoster Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available